Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...

Update 3:10pm: Adds analyst comment. Regeneron (NASDAQ:REGN) won a permanent injunction that blocks drugmakers including, ...

Stuart Williams, chief legal officer for Mylan Pharmaceuticals, insists that the FDA decisions violate the Hatch-Waxman Act, and a court challenge seems likely. There's little doubt that the FDA ...

Upate 2:10pm: Adds analyst comment. Regeneron (NASDAQ:REGN) won a temporary restraining order that blocks drugmakers ...

A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

Heritage is ponying up $10 million while Apotex is set to pay $39.1 million over the companies’ alleged roles in a sweeping ...

Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped ...

A comparative minnow, Torrent Pharmaceuticals, backed by a clutch of private equity players, also made a surprise bid but ...

Using generics results in more robust code and avoids ClassCastExceptions in your Java programs. This in-depth tutorial introduces you to generics and their types and methods. Generics are used in ...

Viatris is poised for appreciation with new product launches and a stronger balance sheet. Read why VTRS stock is a buy due ...

We may not be the first wave launcher in the US, but we have plans." Natco and Mylan have also collaborated on the ...

Generic drugs make up about 40% of the ... Prior to the formation in 2020, Mylan had a debt balance of roughly $12 billion and the combination of Mylan and Upjohn raised additional $12 billion ...